12.66  0.16 (1.28%)		10-24 16:00
Open: 12.73 High: 12.8 Volume: 987,885		Pre. Close: 12.5 Low: 12.51 Market Cap: 2,033(M)

Short term
Mid term
Targets	6-month :	16.21	1-year :	18.93
Resists	First :	13.88	Second :	16.21
Pivot price	12.49
Supports	First :	12.24	Second :	11.22
MAs	MA(5) :	12.49	MA(20) :	12.59
	MA(100) :	11.29	MA(250) :	11.53
MACD	MACD :	0.2	Signal :	0.2
%K %D	K(14,3) :	45.4	D(3) :	39.7
RSI	RSI(14): 55
52-week	High :	15.68	Low :	8.63

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ CERT ] has closed below upper band by 40.8%. Bollinger Bands are 2.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	12.81 - 12.87	12.87 - 12.93
Low:	12.36 - 12.43	12.43 - 12.49
Close:	12.55 - 12.66	12.66 - 12.76

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Thu, 23 Oct 2025
Certara (NASDAQ:CERT) Seems To Use Debt Rather Sparingly - 富途牛牛

Tue, 21 Oct 2025
Certara, Inc. (CERT) Stock Analysis: Navigating a 19.82% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Mon, 20 Oct 2025
11 Certara Scientists on Stanford/Elsevier Top Cited List; Company Publishes 200+ Papers in Past Year - Stock Titan

Sat, 18 Oct 2025
Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance - ADVFN

Fri, 17 Oct 2025
Certara Reduces Borrowing Costs with Credit Amendment - The Globe and Mail

Wed, 15 Oct 2025
Why Investors Should Consider Certara Again (NASDAQ:CERT) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	161 (M)
Shares Float	120 (M)
Held by Insiders	2.4 (%)
Held by Institutions	106.9 (%)
Shares Short	15,450 (K)
Shares Short P.Month	13,440 (K)

EPS	0.05
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	6.67
Profit Margin	1.9 %
Operating Margin	4.9 %
Return on Assets (ttm)	1.3 %
Return on Equity (ttm)	0.7 %
Qtrly Rev. Growth	12.1 %
Gross Profit (p.s.)	1.54
Sales Per Share	2.52
EBITDA (p.s.)	0.65
Qtrly Earnings Growth	0 %
Operating Cash Flow	102 (M)
Levered Free Cash Flow	79 (M)

PE Ratio	253.19
PEG Ratio	0
Price to Book value	1.89
Price to Sales	5.01
Price to Cash Flow	20.02

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.